In models of breast cancer metastasis, SKP2 deficiency attenuates AKT activation, underscoring its role in tumor progression.257 Unlike K63-linked ubiquitination, which primarily regulates AKT activation, K48-linked ubiquitination governs AKT stability, targeting it for proteasomal degradation. The gene discussed is AKT1; the disease is breast carcinoma.